Literature DB >> 23349302

The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.

Rossana Maffei1, Jenny Bulgarelli, Stefania Fiorcari, Linda Bertoncelli, Silvia Martinelli, Carla Guarnotta, Ilaria Castelli, Silvia Deaglio, Giulia Debbia, Sara De Biasi, Goretta Bonacorsi, Patrizia Zucchini, Franco Narni, Claudio Tripodo, Mario Luppi, Andrea Cossarizza, Roberto Marasca.   

Abstract

Macrophages reside in tissues infiltrated by chronic lymphocytic leukemia B cells and the extent of infiltration is associated with adverse prognostic factors. We studied blood monocyte population by flow cytometry and whole-genome microarrays. A mixed lymphocyte reaction was performed to evaluate proliferation of T cells in contact with monocytes from patients and normal donors. Migration and gene modulation in normal monocytes cultured with CLL cells were also evaluated. The absolute number of monocytes increased in chronic lymphocytic leukemia patients compared to the number in normal controls (792 ± 86 cells/μL versus 485 ± 46 cells/μL, P=0.003). Higher numbers of non-classical CD14(+)CD16(++) and Tie-2-expressing monocytes were also detected in patients. Furthermore, we performed a gene expression analysis of monocytes in chronic lymphocytic leukemia patients, showing up-regulation of RAP1GAP and down-regulation of tubulins and CDC42EP3, which would be expected to result in impairment of phagocytosis. We also detected gene alterations such as down-regulation of PTGR2, a reductase able to inactivate prostaglandin E2, indicating immunosuppressive activity. Accordingly, the proliferation of T cells in contact with monocytes from patients was inhibited compared to that of cells in contact with monocytes from normal controls. Finally, normal monocytes in vitro increased migration and up-regulated CD16, RAP1GAP, IL-10, IL-8, MMP9 and down-regulated PTGR2 in response to leukemic cells or conditioned media. In conclusion, altered composition and deregulation of genes involved in phagocytosis and inflammation were found in blood monocytes obtained from chronic lymphocytic leukemia patients, suggesting that leukemia-mediated "education" of immune elements may also include the establishment of a skewed phenotype in the monocyte/macrophage population.

Entities:  

Mesh:

Year:  2013        PMID: 23349302      PMCID: PMC3696616          DOI: 10.3324/haematol.2012.073080

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  37 in total

1.  Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions.

Authors:  Seth B Coffelt; Andrea O Tal; Alexander Scholz; Michele De Palma; Sunil Patel; Carmen Urbich; Subhra K Biswas; Craig Murdoch; Karl H Plate; Yvonne Reiss; Claire E Lewis
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

2.  Immunomodulatory drugs reorganize cytoskeleton by modulating Rho GTPases.

Authors:  Yibing Xu; Jianwu Li; Gregory D Ferguson; Frank Mercurio; Gody Khambatta; Lisa Morrison; Antonia Lopez-Girona; Laura G Corral; David R Webb; Brydon L Bennett; Weilin Xie
Journal:  Blood       Date:  2009-05-05       Impact factor: 22.113

3.  Mast cells and Th17 cells contribute to the lymphoma-associated pro-inflammatory microenvironment of angioimmunoblastic T-cell lymphoma.

Authors:  Claudio Tripodo; Giorgia Gri; Pier Paolo Piccaluga; Barbara Frossi; Carla Guarnotta; Silvia Piconese; Giovanni Franco; Valeria Vetri; Carlo Ennio Pucillo; Ada Maria Florena; Mario Paolo Colombo; Stefano Aldo Pileri
Journal:  Am J Pathol       Date:  2010-07-01       Impact factor: 4.307

4.  Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia.

Authors:  Rossana Maffei; Silvia Martinelli; Rita Santachiara; Davide Rossi; Carla Guarnotta; Elisa Sozzi; Antonella Zucchetto; Gian Matteo Rigolin; Stefania Fiorcari; Ilaria Castelli; Marcella Fontana; Valeria Coluccio; Giovanna Leonardi; Patrizia Zucchini; Claudio Tripodo; Antonio Cuneo; Valter Gattei; Giovanni Del Poeta; Francesco Forconi; Gianluca Gaidano; Giuseppe Torelli; Roberto Marasca
Journal:  Blood       Date:  2010-04-09       Impact factor: 22.113

Review 5.  Antigenic modulation and rituximab resistance.

Authors:  Ronald P Taylor; Margaret A Lindorfer
Journal:  Semin Hematol       Date:  2010-04       Impact factor: 3.851

6.  Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Authors:  Christian Steidl; Tang Lee; Sohrab P Shah; Pedro Farinha; Guangming Han; Tarun Nayar; Allen Delaney; Steven J Jones; Javeed Iqbal; Dennis D Weisenburger; Martin A Bast; Andreas Rosenwald; Hans-Konrad Muller-Hermelink; Lisa M Rimsza; Elias Campo; Jan Delabie; Rita M Braziel; James R Cook; Ray R Tubbs; Elaine S Jaffe; Georg Lenz; Joseph M Connors; Louis M Staudt; Wing C Chan; Randy D Gascoyne
Journal:  N Engl J Med       Date:  2010-03-11       Impact factor: 91.245

7.  Toll-like receptor 4 signaling promotes tumor growth.

Authors:  Che-Hsin Lee; Chao-Liang Wu; Ai-Li Shiau
Journal:  J Immunother       Date:  2010-01       Impact factor: 4.456

8.  Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis.

Authors:  Yuhuan Zheng; Zhen Cai; Siqing Wang; Xiang Zhang; Jianfei Qian; Sungyoul Hong; Haiyan Li; Michael Wang; Jing Yang; Qing Yi
Journal:  Blood       Date:  2009-08-26       Impact factor: 22.113

Review 9.  Non-Edg family lysophosphatidic acid (LPA) receptors.

Authors:  Satoshi Ishii; Kyoko Noguchi; Keisuke Yanagida
Journal:  Prostaglandins Other Lipid Mediat       Date:  2009-06-12       Impact factor: 3.072

10.  Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors.

Authors:  Jérôme Cros; Nicolas Cagnard; Kevin Woollard; Natacha Patey; Shen-Ying Zhang; Brigitte Senechal; Anne Puel; Subhra K Biswas; Despina Moshous; Capucine Picard; Jean-Philippe Jais; David D'Cruz; Jean-Laurent Casanova; Céline Trouillet; Fréderic Geissmann
Journal:  Immunity       Date:  2010-09-09       Impact factor: 31.745

View more
  44 in total

1.  Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.

Authors:  Stefania Fiorcari; Silvia Martinelli; Jenny Bulgarelli; Valentina Audrito; Patrizia Zucchini; Elisabetta Colaci; Leonardo Potenza; Franco Narni; Mario Luppi; Silvia Deaglio; Roberto Marasca; Rossana Maffei
Journal:  Haematologica       Date:  2014-11-14       Impact factor: 9.941

2.  Monocyte function in patients with myelodysplastic syndrome.

Authors:  Daniel A Pollyea; Brenna R Hedin; Brian P O'Connor; Scott Alper
Journal:  J Leukoc Biol       Date:  2018-04-14       Impact factor: 4.962

3.  Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.

Authors:  Paolo Giannoni; Gabriella Pietra; Giorgia Travaini; Rodolfo Quarto; Genti Shyti; Roberto Benelli; Laura Ottaggio; Maria Cristina Mingari; Simona Zupo; Giovanna Cutrona; Ivana Pierri; Enrico Balleari; Alessandra Pattarozzi; Marco Calvaruso; Claudio Tripodo; Manlio Ferrarini; Daniela de Totero
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

Review 4.  Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia.

Authors:  Noelia Purroy; Catherine J Wu
Journal:  Cold Spring Harb Perspect Med       Date:  2017-04-03       Impact factor: 6.915

5.  The PD-1/PD-L1 axis contributes to immune metabolic dysfunctions of monocytes in chronic lymphocytic leukemia.

Authors:  M Qorraj; H Bruns; M Böttcher; L Weigand; D Saul; A Mackensen; R Jitschin; D Mougiakakos
Journal:  Leukemia       Date:  2016-08-01       Impact factor: 11.528

6.  Methylation level of Rap1GAP and the clinical significance in MDS.

Authors:  Wen-Jing Ding; Yi Yang; Zi-Xing Chen; Yuan-Yuan Wang; Wan-Li Dong; Jian-Nong Cen; Xiao-Fei Qi; Feng Jiang; Su-Ning Chen
Journal:  Oncol Lett       Date:  2018-09-26       Impact factor: 2.967

7.  PI3K p110δ inactivation antagonizes chronic lymphocytic leukemia and reverses T cell immune suppression.

Authors:  Shuai Dong; Bonnie K Harrington; Eileen Y Hu; Joseph T Greene; Amy M Lehman; Minh Tran; Ronni L Wasmuth; Meixiao Long; Natarajan Muthusamy; Jennifer R Brown; Amy J Johnson; John C Byrd
Journal:  J Clin Invest       Date:  2018-11-19       Impact factor: 14.808

8.  The pattern of GPI-80 expression is a useful marker for unusual myeloid maturation in peripheral blood.

Authors:  Y Takeda; T Kato; H Ito; Y Kurota; A Yamagishi; T Sakurai; A Araki; H Nara; N Tsuchiya; H Asao
Journal:  Clin Exp Immunol       Date:  2016-10-04       Impact factor: 4.330

9.  Impact of brief exercise on circulating monocyte gene and microRNA expression: implications for atherosclerotic vascular disease.

Authors:  Shlomit Radom-Aizik; Frank P Zaldivar; Fadia Haddad; Dan M Cooper
Journal:  Brain Behav Immun       Date:  2014-01-11       Impact factor: 7.217

10.  Anti-CD20 monoclonal antibody-dependent phagocytosis of chronic lymphocytic leukaemia cells by autologous macrophages.

Authors:  A K Church; K R VanDerMeid; N A Baig; A M Baran; T E Witzig; G S Nowakowski; C S Zent
Journal:  Clin Exp Immunol       Date:  2015-10-28       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.